PROCEPT BioRobotics Corporation Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Carolyn Helms | Sep 21, 2021 | Portfolio News
Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors by Carolyn Helms | Sep 20, 2021 | Portfolio News
RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales by Carolyn Helms | Sep 17, 2021 | Portfolio News
Endeavor BioMedicines Licenses ULK1/2 Inhibitor Program from Salk Institute and Sanford Burnham Prebys to Broaden Its Precision Oncology Pipeline by Carolyn Helms | Sep 16, 2021 | Portfolio News
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures by Carolyn Helms | Sep 16, 2021 | Portfolio News
